Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer (NCT01580982)
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung and Other Thoracic Cancers
🩺 Plain-English Summary (8th-Grade Level)
The mechanisms of sensitivity and resistance to oncogene-targeted therapy can be determined from tumor tissue or tumor cell lines derived from available archival samples and/or from standard-of-care re-biopsy upon suspected tumor progression.
Who can join: Review the eligibility criteria below.
Location: University of Colorado Cancer Center — Aurora, Colorado
Age range: 18 Years to 85 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Colorado Cancer Center — Aurora, Colorado
📞 Contact the Study Coordinator
Phone: (303) 724-1657
Email: brandi.kubala@cuanschutz.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Neoplasms
- A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer — Jacksonville, Florida
- Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations — Gainesville, Florida
- Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) — Mobile, Alabama
- Circulating Tumor Cells (CTC) in Lung Cancer — Indianapolis, Indiana
- Specimen Banking From Patients With Lung Cancer — Aurora, Colorado
- TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics — New Brunswick, New Jersey
Explore by condition: All Lung Neoplasms clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.